The shares of Morgan Stanley (NYSE:MS) has been pegged with a rating of Neutral by Citigroup in its latest research note that was published on April 18th, 2019. The research company has also assigned a $48 price target. Citigroup wasn’t the only research firm that published a report of Morgan Stanley, with other equities research analysts also giving their opinion on the stock. Societe Generale advised investors in its research note published on February 1st, 2019, to Sell the MS stock. The stock had earned Buy rating from Citigroup when it published its report on January 9th, 2019. The stock was given Equal Weight rating by Barclays in its report released on January 2nd, 2019, the day when the price target on the stock was placed at $55. Wells Fargo was of a view that MS is Outperform in its latest report on October 24th, 2018. HSBC Securities thinks that MS is worth Hold rating. This was contained in the firm’s report on October 2nd, 2018.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 6 believe it has the potential for further growth, thus rating it as Hold while 10 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $54.23. The price of the stock the last time has raised by 18.86% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 52.06.
The shares of the company added by 0.88% during the trading session on Tuesday, reaching a low of $43.41 while ending the day at $43.67. During the trading session, a total of 10.64 million shares were traded which represents a 1.07% incline from the average session volume which is 10.75M shares. MS had ended its last session trading at 43.29. Morgan Stanley currently has a market cap of $73.65B, while its P/E ratio stands at 9.38, while its P/E earnings growth sits at 1.45, with a beta of 1.32. Morgan Stanley debt-to-equity ratio currently stands at 5.79, while its quick ratio hovers at . MS 52-week low price stands at $36.74 while its 52-week high price is $52.44.
The company in its last quarterly report recorded $1.39 earnings per share which is above the $1.17 predicted by most analysts. The Morgan Stanley generated $10,286.00 million in revenue during the last quarter, which is slightly lower than the $9,934.75 million predicted by analysts. In the second quarter last year, the firm recorded $0.80 earnings per share. Compared to the same quarter last year, the firm’s revenue was up by 42.45%. Morgan Stanley has the potential to record 4.66 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Jefferies published a research note on April 1st, 2019 where it informed investors and clients that First Horizon National Corporation (NYSE:FHN) is now rated as Hold. Societe Generale also rated FHN as Downgrade on February 1st, 2019, with its price target of $16 suggesting that FHN could surge by 11.66% from its current share price. Even though the stock has been trading at $14.21/share, analysts expect it to surge higher by 2.32% to reach $16.46/share. It started the day trading at $14.71 and traded between $14.29 and $14.54 throughout the trading session.
A look at its technical shows that FHN’s 50-day SMA is 14.47 while its 200-day SMA stands at 15.38. The stock has a high of $19.43 for the year while the low is $12.30. The company’s P/E ratio currently sits at 8.64, while the P/B ratio is 1.04. At the moment, only of First Horizon National Corporation shares were sold short. The company’s average trading volume currently stands at 2.91M shares, which means that the short-interest ratio is just 5.73 days. Over the past seven days, the company moved, with its shift of 1.89%. Looking further, the stock has dropped -2.09% over the past 90 days while it lost -3.84% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc sold more FHN shares, decreasing its portfolio by -0.12% during the last quarter. This move now sees The Vanguard Group Inc selling -36,997 shares in the last quarter, thus it now holds 30,736,493 shares of FHN, with a total valuation of $412,176,371. BlackRock Fund Advisors meanwhile bought more FHN shares in the recently filed quarter, changing its stake to $359,968,452 worth of shares. Fidelity Management Research Co followed the path by decreasing its FHN portfolio by -0.19% in the quarter. This means that Fidelity Management Research Co sold -45,851 shares in the last quarter and now controls 23,875,687 shares of the FHN stock, with the valuation hitting $320,172,963.
Similarly, Franklin Mutual Advisers LLC decreased its First Horizon National Corporation shares by 0.00% during the recently filed quarter. After selling 0 shares in the last quarter, the firm now controls 16,107,427 shares of First Horizon National Corporation which are valued at $216,000,596. In the same vein, SSgA Funds Management Inc decreased its First Horizon National Corporation shares by during the most recent reported quarter. The firm sold -1,095,730 shares during the quarter which decreased its stakes to 12,812,312 shares and is now valued at $171,813,104. Following these latest developments, around 1.20% of First Horizon National Corporation stocks are owned by institutional investors and hedge funds.